File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: MAP30 protein from Momordica charantia is therapeutic and has synergic activity with cisplatin against ovarian cancer in vivo by altering metabolism and inducing ferroptosis

TitleMAP30 protein from Momordica charantia is therapeutic and has synergic activity with cisplatin against ovarian cancer in vivo by altering metabolism and inducing ferroptosis
Authors
Issue Date2020
Citation
Pharmacological Research, 2020, p. 105157 How to Cite?
Persistent Identifierhttp://hdl.handle.net/10722/294182

 

DC FieldValueLanguage
dc.contributor.authorChan, DW-
dc.contributor.authorYung, MH-
dc.contributor.authorChan, YS-
dc.contributor.authorXUAN, Y-
dc.contributor.authorYANG, Y-
dc.contributor.authorXU, D-
dc.contributor.authorZHAN, J-
dc.contributor.authorChan, KKL-
dc.contributor.authorNG, TB-
dc.contributor.authorNgan, HYS-
dc.date.accessioned2020-11-23T08:27:33Z-
dc.date.available2020-11-23T08:27:33Z-
dc.date.issued2020-
dc.identifier.citationPharmacological Research, 2020, p. 105157-
dc.identifier.urihttp://hdl.handle.net/10722/294182-
dc.languageeng-
dc.relation.ispartofPharmacological Research-
dc.titleMAP30 protein from Momordica charantia is therapeutic and has synergic activity with cisplatin against ovarian cancer in vivo by altering metabolism and inducing ferroptosis-
dc.typeArticle-
dc.identifier.emailChan, DW: dwchan@hku.hk-
dc.identifier.emailYung, MH: mhyung@hku.hk-
dc.identifier.emailChan, YS: cys911@hku.hk-
dc.identifier.emailChan, KKL: kklchan@hkucc.hku.hk-
dc.identifier.emailNgan, HYS: hysngan@hkucc.hku.hk-
dc.identifier.authorityChan, DW=rp00543-
dc.identifier.authorityChan, KKL=rp00499-
dc.identifier.authorityNgan, HYS=rp00346-
dc.identifier.doi10.1016/j.phrs.2020.105157-
dc.identifier.hkuros319243-
dc.identifier.spage105157-
dc.identifier.epage105157-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats